Abstract
In recent years, the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) has become popular to prevent or treat massive bleeding due to placenta accreta spectrum (PAS). There are multiple variations in the use of REBOA in this context, and although the experience of vascular surgeons with aortic balloons is extensive, there are particularities in the management of these devices in the obstetric population that deserve to be discussed. We discuss some technical considerations or “lessons learned” in our center that may be useful for other groups starting to use REBOA for PAS. Although REBOA is a useful strategy to prevent or treat massive bleeding due to PAS, its incorporation into management protocols must be carried out in a programmed and supervised manner.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Endovascular Resuscitation and Trauma Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
